Share of Takeda's sales after Shire deal 2019 by region

Published by
Matej Mikulic,
Jul 23, 2019
This statistic depicts the distribution of Takeda Pharmaceutical's sales before and after their deal with Shire as of 2018. According to the data, the distribution of Takeda's sales in the U.S. will increase from 34% to 49% after the deal with Shire.

Distribution of Takeda's sales by region before and after the Shire deal as of 2019

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

January 2019

Region

Worldwide

Survey time period

as of january 2019

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Scandinavia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in Scandinavia

Pharmaceutical sales

8

Patents and clinical trials

6

Trade

5

Key players

6

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical and biotech M&A activitiesGlobal pharmaceutical industryGlobal mergers and acquisitionsMergers and acquisitions in EuropeMergers and acquisitions in the United States
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu